Gloro Romain, Hourmand-Ollivier Isabelle, Mosquet Brigitte, Mosquet Laurent, Rousselot Pierre, Salamé Ephrem, Piquet Marie-Astrid, Dao Thông
Service d'Hépatogastroentérologie et de Nutrition, CHU Côte de Nacre, Caen, France.
Eur J Gastroenterol Hepatol. 2005 Oct;17(10):1135-7. doi: 10.1097/00042737-200510000-00021.
Despite an ancient reputation for potential phytotherapeutic effects and innocuity, traditional herbal medicine has previously been implicated in severe adverse events. Exolise is an 80% ethanolic dry extract of green tea (Camellia sinensis) standardized at 25% catechins expressed as epigallocatechin gallate, containing 5-10% caffeine. It has been available in France, Belgium, Spain and the United Kingdom since 1999, as an adjuvant therapy for use in weight loss programmes. In various studies, green tea has to date been considered useful for its potential hepatic protective properties. In this study, we report a case of fulminant hepatitis during self-medication with Exolise, requiring liver transplantation.
尽管传统草药长期以来因具有潜在的植物治疗作用且无毒无害而闻名,但此前它也曾与严重不良事件有关。Exolise是一种绿茶(茶树)的80%乙醇干提取物,儿茶素含量标准化为25%(以表没食子儿茶素没食子酸酯表示),含有5-10%的咖啡因。自1999年以来,它在法国、比利时、西班牙和英国作为减肥计划中的辅助治疗药物上市。在各种研究中,绿茶迄今为止因其潜在的肝脏保护特性而被认为是有用的。在本研究中,我们报告了一例在自行服用Exolise期间发生暴发性肝炎的病例,该病例需要进行肝移植。